Herbert Meltzer | Schizophrenia | Best Scholar Award

Posted on 22/01/202422/01/2024 by Pencis

Herbert Meltzer | Schizophrenia | Best Scholar Award

👨‍⚕️ Prof. Herbert Y. Meltzer, M.D., is a distinguished psychiatrist currently affiliated with Northwestern University’s Feinberg School of Medicine in Chicago, Illinois. His office is located at 303 East Chicago Avenue, Ward Bldg 7-101, and 680 N. Lakeshore Prof. Suite 1520, Chicago, IL 60611.

🎓 Prof. Meltzer’s academic journey began at Cornell University, where he earned his B.A. with honors in 1958. He continued his education with an M.A. at Harvard University in 1959 and obtained his M.D. from Yale University in 1963, accompanied by a Certificate in Community Psychiatry. Committed to advancing mental health, he participated in the Associate Faculties Program in Community Psychiatry at the Washington School of Psychiatry from 1966 to 1968.

🏆 Prof. Meltzer’s extensive contributions to psychiatry and academic excellence underscore his impact on the field. His current association with Northwestern University reflects a continued dedication to advancing psychiatric research and education. 🌐🧠

Profile

Education

🎓 Prof. Herbert Y. Meltzer’s academic journey is marked by excellence. He earned his B.A. from Cornell University in 1958, showcasing early academic prowess. Subsequently, he pursued an M.A. at Harvard University in 1959 and achieved an M.D. from Yale University in 1963. His commitment to community psychiatry is evident through his Certificate in Community Psychiatry and participation in the Associate Faculties Program in Community Psychiatry at the Washington School of Psychiatry from 1966 to 1968. Prof. Meltzer’s educational trajectory reflects a dedication to advancing mental health knowledge and practice. 🏫📚👨‍⚕️

Honors and Awards

🎓 Dr. Herbert Y. Meltzer, an esteemed figure in the field of chemistry and neuropsychopharmacology, graduated with distinction and honors in chemistry from Cornell University. His academic journey is adorned with prestigious accolades, including the Phi Beta Kappa honor, New York State Regent’s and Cornell University Scholarships, the Dean’s Scholarship at Cornell, the Telluride Associate Scholarship, and the George Chapman Caldwell Prize in Chemistry.

🔬 Dr. Meltzer continued his academic pursuits with a General Electric Fellowship in Chemistry at Harvard and a Dean’s Scholarship at Yale University School of Medicine. Notably, his impactful career includes a Research Scientist Development Award from the National Institute of Mental Health (NIMH) and an Efron Award from the American College of Neuropsychopharmacology. His excellence in academia is further highlighted by the Arthur P. Noyes Award in Schizophrenia from the Commonwealth of Pennsylvania. Dr. Meltzer’s achievements have left an indelible mark on the scientific community, earning him a place in Who’s Who in America. 🏆🧪

Memberships

Dr. Herbert Y. Meltzer holds prestigious memberships in various esteemed organizations, showcasing his dedication to advancing the field of neuropsychopharmacology and psychiatry. As a distinguished member of the American College of Neuropsychopharmacology, American Psychiatric Association, and the American Association for the Advancement of Science, he contributes to cutting-edge research and practices. His involvement in the Collegium Internationale Neuropsychopharmacologicum, New York Academy of Sciences, Society for Neuroscience, Society of Biological Psychiatry, and the International Society for CNS Clinical Trials and Methodology reflects his global engagement in neuroscientific endeavors. 🧠

These memberships underscore Dr. Meltzer’s commitment to staying at the forefront of scientific developments and collaborating with experts worldwide, reinforcing his impact on advancing our understanding of neuropsychopharmacology and mental health. 🌐

Publication top notes

Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study

Pharmacogenomics Journal, 23(5):119–126, 2023.
Link
Citations: 1

Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia

Journal of Clinical Psychopharmacology, 43(3):211–219, 2023.
Link
Citations: 3

Neuroendocrine Studies in Psychiatric Disorders: The Role of Serotonin

The Role of Serotonin in Psychiatric Disorders, 2023, pp. 57–90.
Link
Citations: 7

Role of advanced glycation end products in the longitudinal association between muscular strength and psychotic symptoms among adolescents

Schizophrenia, 8(1):44, 2022.
Link
Citations: 1

Schizophrenia risk loci from xMHC region were associated with antipsychotic response in chronic schizophrenic patients with persistent positive symptom

Translational Psychiatry, 12(1):92, 2022.
Link
Citations: 3

Awareness of illness moderates self-assessment of psychotic symptoms

Australian and New Zealand Journal of Psychiatry, 56(10):1287–1294, 2022.
Link
Citations: 1

Repeated administration of rapastinel produces exceptionally prolonged rescue of memory deficits in phencyclidine-treated mice

Behavioural Brain Research, 432:113964, 2022.
Link
Citations: 1

Lakshmi Rajagopal | Schizophrenia | Best Researcher Award

Posted on 22/01/202422/01/2024 by Pencis

Dr. Lakshmi Rajagopal | Schizophrenia | Best Researcher Award

Dr. Lakshmi Rajagopal, an accomplished Indian researcher in Neuropsychopharmacology, has earned recognition with the Best Researcher Award for her groundbreaking work in schizophrenia. Holding a Ph.D. from the University of Bradford, UK, her dissertation focused on Neonatal Phencyclidine (PCP) induced deficits in rats, contributing to schizophrenia research. With expertise in behavioral testing and immunohistochemistry, Dr. Rajagopal has made significant contributions during her tenure at Northwestern University, Feinberg School of Medicine, Chicago. Currently a Research Assistant Professor, she has excelled in her roles as a Postdoctoral Research Fellow and Research Associate. A recipient of the O1 visa, she is in the process of obtaining an EB1 visa. Dr. Rajagopal’s career showcases a commitment to advancing our understanding of neuropsychiatric disorders. 🏆🧠

Education

Dr. Lakshmi Rajagopal, an esteemed Neuropsychopharmacologist, earned her Ph.D. from the University of Bradford, UK, from 2008 to 2011. Her dissertation, “Neonatal Phencyclidine (PCP) induced deficits in rats,” showcased her expertise in behavioral testing and immunohistochemistry, under the guidance of Prof. Joanna Neill and Dr. Michael Harte at Manchester University. She furthered her academic journey with a Masters in Environmental Protection from Delhi University (1995-1997) and a B.Sc. in Zoology from Women’s Christian College, Chennai (1992-1995). Dr. Rajagopal, dedicated to scientific inquiry, has seamlessly blended her passion for neuroscience and environmental protection. Her academic odyssey is a testament to her commitment to understanding the intricacies of the brain and the environment. 🧠🔬🌿

Experience

Dr. Lakshmi Rajagopal, a dynamic researcher, has played pivotal roles at Northwestern University’s Feinberg School of Medicine since 2012. As a Postdoctoral Research Fellow (2012-2019) and Research Associate (2019-2022), she excelled in behavioral neuroscience, establishing and managing the Behavioral Core of the laboratory. Dr. Rajagopal, currently a Research Assistant Professor, has expertise in diverse behavioral paradigms and techniques such as Western Blot and immunohistochemistry. Notably, she initiated and produced constitutive and conditioned 5-HT7 knock-out mice, contributing to four ongoing first-author research manuscripts. As the DEA liaison, she manages controlled substances, while overseeing IACUC protocols, grant applications, and supervising interns and candidates. In her prior role as Quality Manager at LG Medical Transcription, she efficiently led a team of 500+ editors/transcriptionists from 1999 to 2003. 🧠🔬👩‍🔬

Awards and Honors

Dr. Lakshmi Rajagopal is a distinguished researcher recognized with numerous honors. Acknowledged by the United States Army, Navy, and Air Force, she received a certificate for outstanding mentorship of a summer intern at the Junior Science & Humanities Symposium in 2016. Her commitment to excellence garnered the prestigious “Service Excellence Award” from Northwestern University’s Feinberg School of Medicine in 2017. Dr. Rajagopal’s international acclaim includes Travel Awards from the British Association of Pharmacology for poster presentations in 2009 and 2010, as well as full Travel Awards for abstract/poster presentations at CINP in Florence (2010) and ECNP in France (2008). Notably, she was nominated and featured in Marquis Who’s Who as one of the top researchers in America in 2017. 🏆🌐🔬

Areas of Expertise

Dr. Lakshmi Rajagopal is a distinguished expert in Neuropsychopharmacology, Neuropharmacology, and Behavioral Pharmacology. Her multifaceted expertise encompasses cognition, psychosis, Major Depressive Disorder, Alzheimer’s Disease, and the experimental design of animal behavior tests. Specializing in the pharmacology of preclinical models, she excels in statistical analyses, molecular and neuropathological investigations, and the study of neuroinflammation. Dr. Rajagopal’s comprehensive understanding spans the intricate interplay between pharmacological interventions and neural mechanisms, contributing significantly to the fields of neuroscience and psychiatry. 🧠💊🐭

Publications Top Notes

“The dopamine D1 receptor positive allosteric modulator, DETQ, improves cognition and social interaction in aged mice and enhances cortical and hippocampal acetylcholine efflux.”

Published in Behav Brain Res on Feb 29, 2024.
Link to Publication

“NU-1223, a simplified analog of alstonine, with 5-HT2cR agonist-like activity, rescues memory deficit and positive and negative symptoms in subchronic phencyclidine mouse model of schizophrenia.”

Published in Behav Brain Res on Oct 2, 2023.
Link to Publication

“Repeated Administration of Rapastinel Produces Exceptionally Prolonged Rescue of Memory Deficits in Phencyclidine-Treated Mice.”

Preprint available on SSRN (2022).
Link to Preprint

“Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia.”

Published in Behavioural Brain Research in 2021.
Link to Publication

“Depolarizing GABAA current in the prefrontal cortex is linked with cognitive impairment in a mouse model relevant for schizophrenia.”

Published in Science Advances in 2021.
Link to Publication

“Systematic analysis of brain lactate and pH levels in 65 animal models related to neuropsychiatric conditions.”

Preprint available on BioRxiv in 2021.
Link to Preprint

“The D1 Positive Allosteric Modulator, DETQ, Improves Cognition in Aged Mice and Enhances Cortical and Hippocampal Acetylcholine Efflux.”

Published in Neuropsychopharmacology in 2020.
Link to Publication

“Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action.”

Published in Pharmacology Biochemistry and Behavior in 2020.
Link to Publication

“The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice.”

Published in Behav Brain Res in 2019.
Link to Publication

Yanru Jiang | Representational Learning | Best Researcher Award

Posted on 19/01/202419/01/2024 by Pencis

Ms. Yanru Jiang | Representational Learning | Best Researcher Award

Yanru Jiang is a trailblazing researcher in Representational Learning, currently pursuing a Ph.D. in Communication at the University of California, Los Angeles (UCLA). 🎓 Under the guidance of Dr. Jungseock Joo and Dr. Rick Dale, she has excelled in her academic journey, also earning an M.S. in Statistics. Yanru has garnered prestigious accolades, including being a Meta PhD Fellowship Finalist and securing the UCLA Graduate Council Diversity Fellowship. 🏆 Her dedication extends to research mentorship, as evidenced by her participation in the UCLA Graduate Student Research Mentorship Program. Yanru’s passion for education and innovative contributions make her a standout figure in the academic realm.

Profile

Scopus

Education

Yanru Jiang is on an academic journey marked by excellence, pursuing a Ph.D. in Communication at the University of California, Los Angeles (UCLA) 🎓. Guided by Dr. Jungseock Joo and Dr. Rick Dale, she delves into the intricate realm of communication. Complementing this, Yanru earned an M.S. in Statistics, showcasing her multidisciplinary prowess. 📊 Prior to UCLA, she excelled at the University of Southern California, achieving a Master of Communication Management and a B.S. in Business Administration with a concentration in Cinematic Arts. 🎬 Yanru’s diverse educational background reflects her commitment to interdisciplinary learning and positions her as a standout scholar.

Experience

Yanru Jiang seamlessly blends academic expertise with practical experience, teaching Communication Methods and Film Persuasion at UCLA 📚. As an integral part of UCLA’s Computational Media Lab under PI Jungseock Joo and the Co-Mind Lab led by PI Rick Dale, she explores cutting-edge research in communication and computational media 🧠💻. Yanru has contributed significantly to the field, previously engaging in research at the Artificial Intelligence and Emerging Media Lab at Boston University and diverse projects spanning education, political science, and AI. 🌐 Her dynamic professional background includes roles as an AI Engineer, NLP Research Intern, and Financial Analyst at renowned organizations like Beyond Limits, Testin, and Cybernaut Zfounder Ventures. 🚀

Honors & Awards

Yanru Jiang stands out as a rising scholar, achieving recognition through prestigious awards and fellowships. 🌟 As a Meta PhD Fellowship Finalist (110 of 3200), she exemplifies academic excellence and innovation. Yanru’s commitment to research is underscored by her UCLA ISH Research Innovation Fund Finalist ($100,000) and the UCLA Graduate Council Diversity Fellowship ($66,000). 🏆 Her involvement in impactful programs, such as the UCLA Graduate Student Research Mentorship Program and the USC Center for International Studies Research Assistantship, reflects her dedication to academic exploration. Yanru’s impressive array of grants and awards, including those from APSA and ICA, solidify her position as a distinguished researcher. 🎓

Publication

Automated Nonverbal Cue Detection in Political-Debate Videos: An Optimized RNN-LSTM Approach
- Author: Y. Jiang
- Year: 2024
- 📑🤖
Transformability, generalizability, but limited diffusibility: Comparing global vs. task-specific language representations in deep neural networks
- Authors: Y. Jiang, R. Dale, H. Lu
- Year: 2024
- 📑🧠
The impact of political ideology, knowledge and participation on electoral conspiracy endorsement
- Author: Y. Jiang
- Year: 2023
- 📑🗳️
Validating a Mixed-Method Approach for Multilingual News Framing Analysis: A case study of COVID-19
- Authors: G. Akçakır, Y. Jiang, J. Luo, S. Noh
- Year: 2023
- 📑📰
An Unsupervised Approach to Discover Media Frames
- Authors: S. Lai, Y. Jiang, L. Guo, P. Ishwar, D.T. Wijaya
- Year: 2022
- 📑🔍
David vs. Goliath: transnational grassroots outreach and empirical evidence from the #HongKongProtests Twitter network
- Authors: C.S.Y. Shea, Y. Jiang, W.L.Y. Leung
- Year: 2022
- 📑🌐
Using k-Means Clustering to Classify Protest Songs Based on Conceptual and Descriptive Audio Features
- Authors: Y. Jiang, X. Jin
- Year: 2022
- 📑🎶

Mei Huang | Schizophrenia | Best Researcher Award

Posted on 11/01/202411/01/2024 by Pencis

Mei Huang | Schizophrenia | Best Researcher Award

Dr. Mei Huang 🌟, an accomplished researcher in schizophrenia and neuropharmacology, has dedicated her career to unraveling the complexities of mental health. With a Ph.D. from Shenyang Pharmaceutical University, China, she conducted pioneering postdoctoral research at Vanderbilt University, USA. Serving as a Research Assistant Professor at Northwestern University, Chicago, she’s earned accolades such as the NARSAD Young Investigator Award and CINP Young Investigator Award. 🏆 Dr. Huang’s extensive contributions extend to editorial roles and collaborative grants, investigating novel therapies for cognitive function and neurotransmitter regulation. Her passion for advancing psychiatric understanding is evident in her diverse and impactful research endeavors. 👩‍🔬🧠🔍

Profile:

Scopus

Education:

Dr. Mei Huang’s academic journey reflects a profound commitment to understanding the intricacies of medicine. 📚 From 1994 to 1998, she pursued her Bachelor’s in Pharmacy, specializing in Chinese Traditional Medicine at the esteemed School of Chinese Traditional Medicine, Shenyang Pharmaceutical University, China. 🏛️ Building on this foundation, she earned her Ph.D. in Neuropharmacology from the Department of Pharmacology, School of Pharmacy, Shenyang Pharmaceutical University, from September 1998 to August 2002. 🎓 Her academic pursuits showcase a seamless blend of traditional and modern medicine, setting the stage for a career dedicated to advancing neuropharmacological research. 👩‍🔬🌿🧠

Experience:

Dr. Mei Huang’s academic odyssey seamlessly transitioned from her postdoctoral roles to impactful academic appointments in prestigious institutions. 🌐 Beginning at Shenyang Pharmaceutical University, China, she thrived as a Postdoctoral Research Fellow and Teaching Assistant from August 2002 to July 2003. 🏫 Her journey continued across continents as she pursued postdoctoral research at Vanderbilt University, USA, from August 2003 to July 2008. 🇺🇸 Subsequently, she made significant contributions as a Research Assistant Professor at Vanderbilt University (2008–2012) and later at Northwestern University, Chicago, where she presently serves. 🎓 Dr. Huang’s diverse roles underscore her dedication to advancing knowledge in pharmacology and psychiatry. 👩‍🔬🌟🧠

Award & Honors:

Dr. Mei Huang’s exceptional contributions in schizophrenia research earned her prestigious accolades. 🏆 In 2005, she received the NARSAD Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression, USA, recognizing her groundbreaking work. 🌐 The following year, in 2006, she was honored with the CINP Young Investigator Award, further solidifying her impact on neuro-psychopharmacology. 🧠 Her dedication continued, with another NARSAD Young Investigator Award in 2007, emphasizing her sustained excellence in advancing understanding and treatment of schizophrenia and related mental health disorders. 🌟👩‍🔬🎉

Publications:

“NU-1223, a simplified analog of alstonine, with 5-HT2cR agonist-like activity, rescues memory deficit and positive and negative symptoms in subchronic phencyclidine mouse model of schizophrenia”
- Authors: Rajagopal, L., Mahjour, S., Huang, M., Scheidt, K., Meltzer, H.Y.
- Year: 2023
- Citation: Behavioral Brain Research, 454, 114614
- 🧠🐭🌟
“Repeated administration of rapastinel produces exceptionally prolonged rescue of memory deficits in phencyclidine-treated mice”
- Authors: Rajagopal, L., Huang, M., He, W., Banerjee, P., Meltzer, H.Y.
- Year: 2022
- Citation: Behavioral Brain Research, 432, 113964
- 🔄🐭🌐
“An autophagy-related protein Becn2 regulates cocaine reward behaviors in the dopaminergic system”
- Authors: Kim, Y.-J., Kong, Q., Yamamoto, S., Xu, M., He, C.
- Year: 2021
- Citation: Science Advances, 7(8), eabc8310
- 🍃🧠👃
“Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action”
- Authors: Huang, M., He, W., Rajagopal, L., Grigoriadis, D.E., Meltzer, H.Y.
- Year: 2020
- Citation: Pharmacology Biochemistry and Behavior, 190, 172872
- ⚙️🚶‍♂️🔬
“The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice”
- Authors: Meltzer, H.Y., Rajagopal, L., Matrisciano, F., Svensson, K.A., Huang, M.
- Year: 2019
- Citation: Behavioral Brain Research, 361, 139–150
- 🎯🐭🌈
“Activation of dopamine receptor 2 prompts transcriptomic and metabolic plasticity in glioblastoma”
- Authors: Caragher, S.P., Shireman, J.M., Huang, M., Tryba, A.K., Ahmed, A.U.
- Year: 2019
- Citation: Journal of Neuroscience, 39(11), 1982–1993
- 🧬🧠💡
“The role of dopamine D3 receptor partial agonism in cariprazine-induced neurotransmitter efflux in rat hippocampus and nucleus accumbens”
- Authors: Huang, M., He, W., Kiss, B., Adham, N., Meltzer, H.Y.
- Year: 2019
- Citation: Journal of Pharmacology and Experimental Therapeutics, 371(2), 517–525
- 🔄🐀🔍
“TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA A receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia”
- Authors: Rajagopal, L., Huang, M., Michael, E., Kwon, S., Meltzer, H.Y.
- Year: 2018
- Citation: Neuropsychopharmacology, 43(12), 2468–2477
- 🎓🐭🔬
“5-HT1A partial agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine, and GABA”
- Authors: Huang, M., Kwon, S., Rajagopal, L., He, W., Meltzer, H.Y.
- Year: 2018
- Citation: Psychopharmacology, 235(10), 2795–2808
- 🌈🐭📚
“Dissecting the Functional Consequences of De Novo DNA Methylation Dynamics in Human Motor Neuron Differentiation and Physiology”
- Authors: Ziller, M.J., Ortega, J.A., Quinlan, K.A., Meissner, A., Kiskinis, E.
- Year: 2018
- Citation: Cell Stem Cell, 22(4), 559–574.e9
- 🔬🧬🚶‍♂️

Madhumita Ghosh | Retinal Degeneration and Diabetic retinopathy | Women Researcher Award

Posted on 11/01/202420/07/2024 by Pencis

Madhumita Ghosh | Retinal Degeneration and Diabetic retinopathy | Women Researcher Award

In 2023, Dr. Madhumita Ghosh was honored with the prestigious Woman Researcher Award, a testament to her exceptional contributions in the study of Retinal Degeneration and Diabetic Retinopathy. Her journey began with a Ph.D. from Jadavpur University in 2001, where she demonstrated a profound commitment to academic excellence. Subsequently, she enriched her expertise as a Research Associate at AIIMS, New Delhi, and expanded her horizons through a Visiting Post Doctoral Fellowship at the National Eye Institute, NIH, Bethesda, USA, from 2002 to 2004. Dr. Ghosh further advanced her research at the National Brain Research Center, New Delhi, from 2004 to 2008, before joining the Amity Institute of Biotechnology in 2008 and rising to the position of Associate Professor in 2019. Her dual roles in education—contributing significantly to Animal Biotechnology and Immunology classes—reflect her dedication to both scholarly pursuits and mentorship. The Woman Researcher Award underscores her impactful achievements and underscores her role as a beacon of inspiration for aspiring researchers in her field globally.

Profile:

Scopus

Orcid

Google Scholar

Education:

Dr. Madhumita Ghosh 🌐 embarked on her academic journey with a Ph.D. from Jadavpur University, Kolkata (1995-2001), marking the genesis of her profound expertise. Following this, she contributed as a Research Associate at AIIMS, New Delhi (2001-2002), and broadened her horizons with a Visiting Post Doctoral Fellowship at the National Eye Institute, NIH, Bethesda, USA (2002-2004). Returning to India, she continued her postdoctoral endeavors at the National Brain Research Center, New Delhi (2004-2008). 🧠 These diverse experiences laid the foundation for her illustrious career, positioning her as a seasoned researcher with a global perspective in the realm of neuroscience. 🌍👩‍🔬

Experience:

From 2008 to 2011, Dr. Madhumita Ghosh assumed the role of Senior Lecturer at the Amity Institute of Biotechnology, Amity University, Noida, India, contributing significantly to academic growth. 🎓 Transitioning seamlessly, she served as an Assistant Professor from 2011 to 2019, leaving an indelible mark on the institution’s biotechnology landscape. 🌱 Her dedication and prowess have been further acknowledged since 2019, as she currently holds the position of Associate Professor at the Amity Institute of Biotechnology. 🚀 Dr. Ghosh’s enduring commitment to education underscores her influential role in shaping the next generation of biotechnologists. 👩‍🏫🔬

Research Activity:

Dr. Madhumita P. Ghosh 🌟, an accomplished Associate Professor at Amity Institute of Biotechnology since 2019, boasts a stellar research portfolio. 🧪 Her impactful work includes a Department of Biotechnology grant in 2016, exploring lithium’s antiapoptotic properties against retinal ganglion cell degeneration. 🤖 She led a Department of Science and Technology project (2017-2020) on dopamine treatment in diabetic retinopathy, unraveling insights into angiogenesis. 🩸👁 Currently, she mentors a Ph.D. student in a project studying VEGF’s role using Trolox and CoQ10 against NMDA-induced toxicity. Her groundbreaking contributions to retinal research showcase her dedication and leadership in advancing eye health. 👩‍🔬🔍✨

Publications:

“Trolox aids coenzyme Q10 in neuroprotection against NMDA induced damage via upregulation of VEGF in rat model of glutamate excitotoxicity”

Authors: Upreti, S., Nag, T.C., Ghosh, M.P.

Year: 2024

Citation: Experimental Eye Research, 238, 109740

🧠👁✨

“Insulin-like growth factor-1 works synergistically with dopamine to attenuate diabetic retinopathy by downregulating vascular endothelial growth factor”

Authors: Upreti, S., Sen, S., Nag, T.C., Ghosh, M.P.

Year: 2022

Citation: Biomedicine and Pharmacotherapy, 149, 112868

🔄🌱👁

“Trolox assisted inhibition of glutamate excitotoxicity-mediated degeneration in retina”

Authors: Upreti, S., Ghosh, M.P.

Year: 2022

Citation: Contemporary Medical Biotechnology Research for Human Health, pp. 79–90

🧪👁🚫

“Rapid Electrochemical Quantification for In Vitro Release Trait of Ophthalmic Drug Loaded within Mucoadhesive Metal Organic Framework (MOF)”

Authors: Chansi, Upreti, Punya, Ghosh, M.P., Basu, T.

Year: 2021

Citation: ChemistrySelect, 6(12), pp. 3006–3012

⚡💧👁

“Mutations associated with retinopathies alter mitogen-activated protein kinase-induced phosphorylation of neural retina leucine-zipper”

Authors: Swain, P., Kumar, S., Patel, D., Ghosh, M., Swaroop, A.

Year: 2007

Citation: Molecular Vision, 13, pp. 1114–1120

🧬🔄👁

“Lack of fiber cell induction stops normal growth of rat lenses in organ culture”

Author: Ghosh, M.P., Zigler Jr., J.S.

Year: 2005

Citation: Molecular Vision, 11, pp. 901–908

🧪👁🔒

“A spontaneous mutation affects programmed cell death during development of the rat eye”

Authors: Sinha, D., Hose, S., Zhang, C., Ghosh, M.P., Lo, W.-K., Zigler Jr., J.S.

Year: 2005

Citation: Experimental Eye Research, 80(3), pp. 323–335

🌀💔👁

Paola Valentino | Biomarkers | Best Researcher Award

Posted on 08/01/202408/01/2024 by Pencis

Dr. Paola Valentino | Biomarkers | Best Researcher Award

🔬 Dr. Paola Valentino, a trailblazing leader in biomarkers at the University of Turin, spearheads groundbreaking initiatives in translational research. 🌐 As the driving force behind the establishment of the Department’s biobank, she expertly manages cryogenic facilities, informed consent procedures, and sample/data documentation. Her extensive research fellowship at the Neuroscience Institute focused on Multiple Sclerosis and NMOSD, delving into biomarkers like Neurofilament Light Chain and anti-aquaporin 4 antibodies. 🧪 Dr. Valentino excels in quality management, shaping the CRESM Biobank’s protocols and legal documents while actively contributing to national and international biobanking initiatives. 🌍 Her rich background, spanning from gene expression analysis to board certification in clinical and analytical biochemistry, showcases her multidisciplinary prowess. 🎓 Fluent in Italian, with proficiency in English and French, Dr. Valentino is a dynamic force in the intersection of science, ethics, and biobanking standards. 🌟

Profile:

Scopus

Orcid

Education:

👩‍🎓 Dr. Paola Valentino, a Turin native, embarked on her academic journey with a Bachelor’s degree in Medical Biotechnology (L1) from the University of Turin in 2003. 🎓 Her commitment to excellence continued as she earned a Master’s degree in Medical Biotechnology (9/S) on 23/07/2003, solidifying her expertise in the field. 🧪 Driven by a passion for analytical biochemistry, she achieved Board Certification in Clinical and Analytical Biochemistry from the University of Turin on 27/07/2005. 🏆 These educational milestones laid the foundation for her remarkable career as a leader in biomarker research and biobanking. 🌟

Experience:

🌟 Dr. Paola Valentino is a dynamic force in the world of biomarkers, currently serving as Technical Administrative Personnel at the University of Turin since 03/07/2023. 🏛️ Her impactful role involves establishing the biobank for the Department of Clinical and Biological Sciences, overseeing cryogenic facilities, documentation, informed consent, and managing samples and data. 🧪 Concurrently, she engages in cutting-edge translational research activities, focusing on biomarkers.

🔬 Prior to her current position, Dr. Valentino held a significant role at the Neuroscience Institute Cavalieri Ottolenghi (NICO)/University Hospital San Luigi Gonzaga from 18/09/2006 to 30/06/2023. During this tenure, her research spanned multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Notably, she pioneered studies on Neurofilament Light Chain as a biomarker, validated methods for anti-aquaporin 4 antibodies, and explored the diagnostic potential of anti-potassium channel KIR4.1 antibodies.

🌐 Dr. Valentino’s impact extends to quality management in the CRESM biobank since 08/04/2021, where she defines sample collection protocols, updates databases, implements biobank software, and ensures compliance with ethical and legal standards, including GDPR. 🌍 Her diverse expertise also includes participating in international biobanking working groups, contributing to standards like UNI ISO 20387, and collaborating on gene expression analysis with the Italian Foundation for Multiple Sclerosis. 🤝 Dr. Valentino’s multifaceted contributions solidify her as a key figure in the intersection of research, biobanking, and quality management.

Publication:

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
- Author: Carta, S., Dinoto, A., Capobianco, M., … Marignier, R., Mariotto, S.
- Year: 2024
- Journal: Neurology(R) Neuroimmunology & Neuroinflammation, 11(1), pp. e200188
Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
- Authors: Zanghì, A., Ferraro, D., Callari, G., … Avolio, C., D’amico, E.
- Year: 2024
- Journal: Current Neuropharmacology, 22(2), pp. 339–345

Cerebrospinal fluid neurofilament light chains predict early disease activity in Multiple Sclerosis
- Authors: Toscano, S., Oteri, V., Chisari, C.G., … Zappia, M., Patti, F.
- Year: 2023
- Journal: Multiple Sclerosis and Related Disorders, 80, 105131

Correction to: Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease (Journal of Neurology)
- Authors: Bellofatto, M., Gentile, L., Bertini, A., … Iabichella, G., Barone, S.
- Year: 2023
- Journal: Journal of Neurology, 270(11), pp. 5569–5570

Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease
- Authors: Bellofatto, M., Gentile, L., Bertini, A., … Iabichella, G., Barone, S.
- Year: 2023
- Journal: Journal of Neurology, 270(11), pp. 5561–5568

Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
- Authors: Mosconi, P., Guerra, T., Paletta, P., … Zaffaroni, M., Zarbo, R.
- Year: 2023
- Journal: Neurological Sciences, 44(11), pp. 4001–4011

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients
- Authors: Valentino, P., Malucchi, S., Bava, C.I., … Di Sapio, A., Bertolotto, A.
- Year: 2023
- Journal: Multiple Sclerosis and Related Disorders, 77, 104893

Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey
- Authors: Altieri, M., Capuano, R., Bisecco, A., … Tedeschi, G., Gallo, A.
- Year: 2023
- Journal: Multiple Sclerosis and Related Disorders, 77, 104870

The one-and-a-half syndrome: a distinctive clinical finding in a patient with multiple sclerosis
- Authors: Fratto, E., Barone, S., Tinelli, E., … Gambardella, A., Valentino, P.
- Year: 2023
- Journal: Neurological Sciences, 44(9), pp. 3331–3333

Clinical spectrum and frequency of Charcot–Marie–Tooth disease in Italy: Data from the National CMT Registry
- Authors: Pisciotta, C., Bertini, A., Tramacere, I., … Vita, G., Pareyson, D.
- Year: 2023
- Journal: European Journal of Neurology, 30(8), pp. 2461–2470

Saad Javeed | Cervical spine disease | Best Researcher Award

Posted on 06/01/202406/01/2024 by Pencis

Dr.Saad Javeed | Cervical spine disease | Best Researcher Award

👨‍⚕️ Saad Javeed is a dynamic medical professional currently serving as a Resident in General Surgery at Washington University School of Medicine. 🎓 With a background in Neurosurgery and a Master’s in Clinical Investigation, he is a dedicated researcher, earning the Best Researcher Award for his work on cervical spine diseases. 🌐 Hailing from Sharif Medical and Dental College in Lahore, Pakistan, Saad’s journey includes impactful roles as a Postdoctoral Research Fellow and Research Trainee, contributing significantly to nerve transfer surgeries, spinal cord injury outcomes, and bone growth induction. 🏥 Committed to clinical excellence, his leadership shines through various roles, fostering literary and scientific discourse(Cervical spine disease).

Profile:

Scopus

Education:

👨‍🎓 Saad Javeed embarked on his medical journey at Sharif Medical and Dental College in Lahore, Pakistan, graduating with distinction with a Bachelor of Medicine, Bachelor of Surgery (M.B.B.S) from 2012 to 2017. 🏥 During this time, he immersed himself in core clinical rotations at Sharif Medical City and Ittefaq Trust Hospital, Lahore, while also dedicating his time as a volunteer in the Emergency department.

🌐 Expanding his horizons, Saad pursued a Master of Science in Clinical Investigation (MSCI) at Washington University School of Medicine in St. Louis, MO, from 2021 to 2023. 🧪 His research focus during this period involved a cutting-edge project on biomarker discovery in Chronic Entrapment Neuropathy. 🤝 Under the guidance of primary mentor Dr. Wilson Ray and secondary mentor Dr. David Brogan, Saad showcased his commitment to advancing medical knowledge and improving patient outcomes. 🌟

Research:

🌐 Saad Javeed, a dedicated Postdoctoral Research Fellow at Ray Lab, Neurosurgery, Washington University School of Medicine, explores the intricate realm of spinal health. Under the mentorship of Dr. Wilson Z. Ray, M.D., his clinical endeavors delve into nerve transfers for cervical spinal cord injuries, optimizing treatment algorithms for tetraplegia, and pioneering research in spinal cord injury outcomes and predictive modeling. 🤖 Additionally, Saad integrates mobile health technology into spinal surgery outcomes. In the realm of basic science, he investigates electrical stimulation for bone growth post-fracture and spinal fusion, objective biomarkers in chronic entrapment neuropathy, and techniques to enhance nerve regeneration after peripheral nerve injury. 🧠🔬

Clinical experience:

👨‍⚕️ Saad Javeed’s medical journey unfolds as a Preliminary Resident in General Surgery (PGY1) at Washington University School of Medicine since 2023, showcasing his commitment to surgical excellence. 🌟 His summer of 2022 was marked by a Sub-Internship in Neurosurgery at the same institution, honing his skills in this specialized field. 🧠 Prior experiences include a Neurosurgery Clinical Observership at the University of Miami Miller School of Medicine in 2019 and a Spring 2019 Clinical Observership in Neurology at the University of South Florida School of Medicine. 🏥 In 2018-2019, Saad engaged in a Clinical Elective, serving as a Medical Scribe at Dominion Cardiovascular Specialists in Richmond, VA. 💉

Honors and Awards:

🏆 Saad Javeed’s accolades form a stellar constellation, reflecting his prowess in medicine and research. In 2016, he earned the Student Medical Volunteer Award at Sharif Medical City and assumed the role of Student President of the Literary Society at Sharif Medical and Dental College. 📷 His artistic talents were recognized with the Best Abstract Portrait in the Intercollegiate Medical College Photography Competition. Fast forward to 2021 and beyond, Saad’s contributions reached new heights, including a Journal Cover Illustration Award from JNS Spine and a string of honors for abstract presentations and posters at prestigious conferences, solidifying his status as a trailblazer in peripheral nerve surgery. 🌟🧠

Publications:

📚 Publication: “Revision Anterior Cervical Discectomy and Fusion and Revision Cervical Arthroplasty Are Associated with Similar Outcomes: Real-World Analysis from a National Quality Registry”

👥 Authors:

Tsai, S.H.L.
Alvi, M.A. 🧠
Tazyeen, S.
Bydon, M.
Elder, B.D.

📅 Year: 2021

🔗 Journal: Turkish Neurosurgery, 31(6), pp. 952–961

📚 Publication: “Prevalence and Trends in Management of Idiopathic Normal Pressure Hydrocephalus in the United States: Insights from the National Inpatient Sample”

👥 Authors:

Alvi, M.A. 🧠
Brown, D.
Yolcu, Y.
Cogswell, P.M.
Elder, B.D.

📅 Year: 2021

🔗 Journal: World Neurosurgery, 145, pp. e38–e52

Dr. Hossein Banki-Koshki | Mental Disorder | Best Researcher Award

Posted on 04/01/202405/01/2024 by Pencis

Dr. Hossein Banki-Koshki | Mental Disorder | Best Researcher Award

PhD Candidate in Biomedical Engineering, Amirkabir University of Technology (AUT), Iran.

Dr. Hossein Banki-Koshki is a distinguished researcher and recipient of the Best Researcher Award in the field of Mental Disorders. His academic journey has been a dynamic exploration of the intersection between technology and life sciences. Driven by an insatiable curiosity, he earned his Bachelor’s degree in Biomedical Engineering (Bioelectrics) from AUT in 2015, immersing himself in the electrifying realm of bioengineering. The spark ignited during his undergraduate years propelled him to further heights, leading him to pursue a Master’s in Biomedical Engineering with a specialization in Biomedical Informatics at AUT from 2016 to 2018. This postgraduate expedition was a harmonious blend of cutting-edge technology and the intricacies of biomedical data, sculpting Dr. Banki-Koshki into a versatile professional. His academic chapters form a compelling narrative of dedication to unraveling the mysteries of biomedical sciences through the innovative lens of engineering solutions. Beyond his academic prowess, Dr. Banki-Koshki’s notable achievements include the Best Researcher Award, showcasing his impactful contributions to the understanding and advancement of mental health disorders.

Scopus

Google Scholar

Research Gate

EDUCATION :

In the vibrant realm of academia, my educational journey has been a thrilling exploration of the intersection between technology and life sciences. Embarking on this intellectual odyssey, I earned my Bachelor’s degree in Biomedical Engineering (Bioelectrics) from AUT in 2015, delving deep into the electrifying realm of bioengineering. The spark ignited during my undergraduate years fueled my passion, leading me to pursue a Master’s in Biomedical Engineering with a specialization in Biomedical Informatics at AUT from 2016 to 2018. This postgraduate expedition was a dynamic blend of cutting-edge technology and the intricacies of biomedical data, shaping me into a versatile professional. The amalgamation of these academic chapters paints a vivid picture of my commitment to unraveling the mysteries of biomedical sciences through the lens of innovative engineering solutions. 🧠🔬✨

Experience :

Embarking on the pinnacle of his academic journey, he is currently immersed in the captivating realm of Bioelectrical Engineering as a diligent PhD student at Amirkabir University of Technology (AUT) in Tehran, Iran. His doctoral thesis delves into the intriguing intersection of chaos theory and neural networks, offering a unique perspective on modeling cognitive processes. The fruits of his labor have manifested in the publication of one ISI article and two domestic papers, contributing to the ever-expanding landscape of knowledge. With the imminent defense of his doctoral thesis in the next two months, the excitement and anticipation are palpable. His academic trajectory, marked by the completion of a master’s degree in Biomedical Information Engineering and a bachelor’s degree in Bioelectric Engineering, reflects his steadfast commitment to the field. Grateful for the opportunity to pursue both master’s and doctoral degrees through the talented student’s quota, he holds a TOEFL certificate, underscoring his proficiency in English. Beyond academia, his current role as a designer of intelligent tracking and tracing systems at the Iranian Ministry of Health, Food and Drug Organization, Medical Equipment Department, allows him to apply his expertise in real-world scenarios, contributing to advancements in healthcare technology. 🎓🔬🧠✨

Publications Top Notes :

Transcription factor binding sites identification on human genome using an artificial neural network

Citation : 2

Year : 2017

Complexity emerging from simplicity: Bifurcation analysis of the weights time series in a feedforward neural

Citation : 1

Year : 2023

network Weight synchronization in feedforward neural networks and a novel method to detect synchrony patterns

Year : 2023

A Novel Neuronal Model based on Chaotic Behavior of Artificial Neural Networks

Year : 2021

Dimensionality Reduction of Binding Site Sequence Data on Human Genome Using a Deep Autoencoder Neural Network

Year : 2018

Marcello D’Amelio | Neuroinflammation | Excellence in Research

Posted on 02/01/202403/01/2024 by Pencis

Marcello D’Amelio | Neuroinflammation | Excellence in Research

Director Unit of Molecular Neurosciences AT University Campus Bio-medico, Italy

Prof. Dr. Marcello D’Amelio is an esteemed professional in the field of medical sciences, hailing from the University Campus Bio-medico in Italy. 🇮🇹 With a rich educational background, he embarked on his academic journey at the University of Bari, Italy, earning his Master’s degree in Medical Genetics in 1994.

Driven by a passion for advancing knowledge, Dr. D’Amelio pursued a Ph.D. at the University of Rome, “Tor Vergata,” specializing in Neurosciences, completing his doctoral studies in 2005. 🧠 His commitment to the medical field led him to further academic achievements, obtaining a Master’s degree in Clinical Research from the University of Rome, “La Sapienza,” in 2009.

Throughout his educational endeavors, Dr. D’Amelio has demonstrated a keen interest and expertise in diverse aspects of medical sciences, ranging from genetics to neuroscience and clinical research. 🧬🔬 His academic pursuits and contributions underscore his dedication to advancing the understanding and application of medical knowledge.

PROFILE

scopus

EDUCATION

Prof. Dr. Marcello D’Amelio, an accomplished professional in the realm of medical sciences, commenced his academic journey at the University of Bari, Italy, earning a Master’s degree in Medical Genetics in 1994. 🎓 Subsequently, he delved into the intricacies of Neurosciences at the University of Rome, “Tor Vergata,” where he attained his Ph.D. in 2005, showcasing a commitment to advancing our understanding of the brain and nervous system. 🧠

Driven by a thirst for knowledge, Dr. D’Amelio furthered his academic pursuits, obtaining a Master’s degree in Clinical Research from the University of Rome, “La Sapienza,” in 2009. 🏥 This diverse educational background underscores his expertise in bridging genetics, neuroscience, and clinical research, contributing significantly to the medical field. 🌐 His dedication to multifaceted medical studies positions him as a versatile and accomplished professional in the ever-evolving landscape of healthcare and research.

Experience

From 2015 to 2018, Dr. Marcello D’Amelio served as an Associate Professor in Human Physiology at the Department of Medicine and Surgery, University Campus Bio-medico in Rome, Italy. 🏛️ Prior to this, he held the position of Assistant Professor from 2010 to 2014, contributing significantly to the academic landscape. 🎓 His journey into academia began with a Post-doctoral role at the Dulbecco Telethon Institute, Tor Vergata University, Rome, supported by a prestigious Telethon Fellowship from 2008 to 2010. 🌐

Dr. D’Amelio’s global research exposure includes visiting scientist roles at renowned institutions such as Vanderbilt University Medical Center and the University of Washington School of Medicine in the United States. 🌍 The recipient of multiple fellowships, including a PhD fellowship at the Laboratory of Molecular Psychiatry, he has consistently demonstrated excellence in the field of human physiology and molecular research. 🧬✨

Awards

Dr. Marcello D’Amelio’s outstanding contributions to neuroscience have been recognized with prestigious accolades. In 2010, he was honored with the Neuroscience Research Prize by the Telethon Foundation, acknowledging his impactful work. 🏆 His dedication to translational research in neurodegeneration garnered the 2013 Bioeconomy Rome International Prize, celebrating young Italian scientists. 🌐 The following year, the Raffaele Giuliano Prize acknowledged him for the quality and originality of his scientific production. 🎉 In 2017, the Italian Minister of Health, Beatrice Lorenzin, bestowed upon him a distinguished award for his remarkable scientific merits, further solidifying his position as a leader in the field. 🇮🇹🧠

Publications Top Notes

Early derailment of firing properties in CA1 pyramidal cells in an Alzheimer’s disease mouse model
- Published in: Experimental Neurology, 2022
- Authors: Spoleti E., Krashia P., La Barbera L., Nobili A., Lupascu C. A., Giacalone E., Keller F., Migliore M., Renzi M., D’Amelio M.
- DOI: 10.1016/j.expneurol.2021.113969
- 🧠🐭📚
Nilotinib restores memory function in an Alzheimer’s disease mouse model
- Published in: Progress in Neurobiology, 2021
- Authors: La Barbera L, Vedele F, Nobili A, Krashia P, Spoleti E, Latagliata EC, Cutuli D, Cauzzi E, Marino R, Viscomi MT, Petrosini L, Puglisi-Allegra S, Melone M, Keller F, Mercuri NB, Conti F, D’Amelio M
- 🐭🧠📖
Targeting autophagy as a therapeutic strategy in early Alzheimer’s disease
- Published in: Autophagy, 2021
- Authors: Nobili A, La Barbera L, D’Amelio M
- DOI: 10.1080/15548627.2021.1909409
- 🎯🔄🧠
Ventral Tegmental Area in Prodromal Alzheimer’s Disease: Bridging the Gap between Mice and Humans
- Published in: Journal of Alzheimer’s Disease, 2018
- Authors: D’Amelio M, Serra L, Bozzali M.
- DOI: 10.3233/JAD-180094
- 🌐🐭🧠
In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer’s disease
- Published in: Neurobiology of Aging, 2018
- Authors: Serra L, D’Amelio M*, Di Domenico C, Dipasquale O, Marra C, Mercuri NB, Caltagirone C, Cercignani M, Bozzali M. (*Co-first)
- DOI: 10.1016/j.neurobiolaging.2018.08.012
- 🌍🧠🔄